speb/financial-data huggingface dataset:
Financial ratios for GFR — annual report dated 2025-12-31
Total revenue: 440367153.2846715
Gross profit: 195633576.64233574
Operating income: 43267153.28467153
Net income: 34674452.55474452
Capital expenditures: 8425547.445255473
Operating cash flow: 99606569.34306568
Depreciation & amortization: 61496350.3649635
Net tangible assets: 851720437.9562043
Owner earnings: 87745255.47445254
Return on net tangible assets (%): 10.302119282825572
Capex to operating income (%): 19.473311289560698
Buffett classification: The Great
Stock price: 4.76
P/E ratio: 17.218499385314924
Shares outstanding: 125429000
Book value: 851720437.9562044
P/B ratio: 0.7009835779362852
Market cap (USD): 597042040
Debt to equity: 0.005232003578844708
Current ratio: 1.5567636378813807
Quick ratio: 1.341854835343712
Effective tax rate (%): 14.133362254396905
Interest coverage ratio: 1.4228175031804324
COGS to revenue (%): 55.57489354437158
SG&A to revenue (%): 12.549581222039341
Free cash flow (dilution-adjusted): 15891970.802919706
Buyback yield (%): 0
Retained earnings: 507745985.4014598
Inventory turnover: 16.27913187026607
Receivables turnover: 9.115266068352824
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.982817869415808
FCF margin (%): 3.608800221447598
Revenue growth (%): -23.481597284345007
Rule of 40 score: -19.87279706289741
Financial ratios for GMAT3.SA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.9929824561403509
Shares outstanding: 2302987204
Market cap (USD): 2286825890.2877192
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GMAT3.SA — annual report dated 2022-12-31
Total revenue: 4122817613.6363635
Gross profit: 908909469.6969696
Operating income: 241809659.0909091
Net income: 201665719.6969697
Capital expenditures: 113441098.48484848
Operating cash flow: 185185227.27272725
Depreciation & amortization: 62342424.24242424
Net tangible assets: 1411191477.2727273
Owner earnings: 150567045.45454544
Return on net tangible assets (%): 10.669497929900466
Capex to operating income (%): 46.91338588844375
Buffett classification: The Good
Stock price: 1.127134724857685
P/E ratio: 12.871681178297525
Shares outstanding: 2302987204
Book value: 1428406249.9999998
P/B ratio: 1.817253913955718
Market cap (USD): 2595776848.5313096
Debt to equity: 0.42342765200408117
Current ratio: 3.196208177250516
Quick ratio: 1.7657214167779858
Effective tax rate (%): 2.1610491089887662
Interest coverage ratio: 8.580631069592393
COGS to revenue (%): 77.95416739535797
SG&A to revenue (%): 16.589277237906906
Free cash flow (dilution-adjusted): 20312121.21212121
Buyback yield (%): 0
Inventory turnover: 4.308466787267131
Receivables turnover: 8.54250004709103
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.147317677253575
FCF margin (%): 0.49267571635810814
Rule of 40 score: 0.49267571635810814
Financial ratios for GMAT3.SA — annual report dated 2023-12-31
Total revenue: 5520327010.3092785
Gross profit: 1198541855.670103
Operating income: 346930103.0927835
Net income: 254564536.08247423
Capital expenditures: 211362886.59793815
Operating cash flow: 196778969.07216495
Depreciation & amortization: 72864329.89690723
Net tangible assets: 1646636082.474227
Owner earnings: 116065979.38144329
Return on net tangible assets (%): 7.048672175763521
Capex to operating income (%): 60.92376669354949
Buffett classification: The Good
Stock price: 1.3954451345755694
P/E ratio: 12.624273350355514
Shares outstanding: 2302987204
Book value: 1671055463.917526
P/B ratio: 1.923151180917478
Market cap (USD): 3213692288.8115945
Debt to equity: 0.4653852327913255
Current ratio: 2.209078246252712
Quick ratio: 1.2472183071158924
Effective tax rate (%): 3.339105980796813
Interest coverage ratio: 7.176721233163009
COGS to revenue (%): 78.28857143006543
SG&A to revenue (%): 5.496510628049601
Free cash flow (dilution-adjusted): -53246391.75257733
Buyback yield (%): 0.04789429476775256
Retained earnings: -46864329.89690722
Inventory turnover: 5.144756280958691
Receivables turnover: 7.7433390752272935
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.691864047097477
FCF margin (%): -0.9645514052544176
Revenue growth (%): 33.89694931084518
Rule of 40 score: 32.93239790559076
Financial ratios for GMAT3.SA — quarterly report dated 2024-09-30
Operating income: 101797605.893186
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.3075506445672191
Shares outstanding: 2302987204
Market cap (USD): 3011272403.020258
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GMAT3.SA — annual report dated 2024-12-31
Total revenue: 5191816828.478965
Gross profit: 1159504692.5566344
Operating income: 323055016.18122977
Net income: 206432362.45954692
Capital expenditures: 174500647.24919096
Operating cash flow: 236407119.74110034
Depreciation & amortization: 60962135.9223301
Net tangible assets: 1471593851.1326861
Owner earnings: 92893851.13268605
Return on net tangible assets (%): 6.312465294767685
Capex to operating income (%): 54.015767751242194
Buffett classification: The Good
Stock price: 0.9951534733441033
P/E ratio: 11.102066012429313
Shares outstanding: 2302987204
Book value: 1493898543.6893206
P/B ratio: 1.5341240707469663
Market cap (USD): 2291825715.127625
Debt to equity: 0.48689583400353514
Current ratio: 2.3241799604129887
Quick ratio: 1.2865042529289037
Effective tax rate (%): 10.663080927630968
Interest coverage ratio: 7.500798364948586
COGS to revenue (%): 77.66668719519653
SG&A to revenue (%): 5.439992883997059
Free cash flow (dilution-adjusted): 31123624.59546926
Buyback yield (%): 0.07637951809942602
Retained earnings: 21004692.556634307
Inventory turnover: 5.138802817220896
Receivables turnover: 9.439305940049366
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.728824971779611
FCF margin (%): 0.5994746275474337
Revenue growth (%): -5.950918871596137
Rule of 40 score: -5.351444244048704
Financial ratios for GMAT3.SA — quarterly report dated 2024-12-31
Capital expenditures: 202636084.14239484
Buffett classification: The Gruesome
Stock price: 0.9951534733441033
Shares outstanding: 2302987204
Market cap (USD): 2291825715.127625
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GMAT3.SA — quarterly report dated 2025-03-31
Total revenue: 1446407118.0555556
Gross profit: 321639409.7222222
Operating income: 83444097.22222222
Net income: 47972222.222222224
Capital expenditures: 55031944.44444445
Operating cash flow: 84191840.27777778
Depreciation & amortization: 18280208.333333336
Net tangible assets: 1727386458.3333335
Owner earnings: 11220486.111111112
Return on net tangible assets (%): 0.6495643205364238
Capex to operating income (%): 65.95067389594664
Buffett classification: The Good
Stock price: 1.1440972222222223
P/E ratio: 13.73107780323538
Shares outstanding: 2302987204
Book value: 1758635416.6666667
P/B ratio: 1.4982305246097136
Market cap (USD): 2634841262.9097223
Debt to equity: 0.4633625344776865
Current ratio: 2.4048354333178086
Quick ratio: 1.1866396916654929
Effective tax rate (%): 7.704126793259515
Interest coverage ratio: 3.1413632412436354
COGS to revenue (%): 77.76287148291895
SG&A to revenue (%): 5.453299333057666
Free cash flow (dilution-adjusted): 22412847.222222224
Buyback yield (%): 0.10676902946850629
Retained earnings: 174302083.33333334
Inventory turnover: 1.0163869770173801
Receivables turnover: 2.282018511310657
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2293733367707382
FCF margin (%): 1.5495531612394458
Rule of 40 score: 1.5495531612394458
Financial ratios for GMAT3.SA — quarterly report dated 2025-06-30
Total revenue: 1602123357.6642334
Gross profit: 369172445.25547445
Operating income: 107997262.77372262
Net income: 63722445.25547445
Capital expenditures: 43389963.50364963
Operating cash flow: 16887591.24087591
Depreciation & amortization: 20637408.759124085
Net tangible assets: 1851771532.8467152
Owner earnings: 40969890.510948904
Return on net tangible assets (%): 2.212470047423517
Capex to operating income (%): 40.17691040425802
Buffett classification: The Good
Stock price: 1.4616788321167882
P/E ratio: 30.13776505843307
Shares outstanding: 2302987204
Book value: 1886723905.1094892
P/B ratio: 1.784165472015515
Market cap (USD): 3366227646.722627
Debt to equity: 0.48137615824440594
Current ratio: 2.340176155169266
Quick ratio: 1.1399237128272315
Effective tax rate (%): 8.770541055986623
Interest coverage ratio: 3.3968030763932733
COGS to revenue (%): 76.95730210227396
SG&A to revenue (%): 5.5323592003130875
Free cash flow (dilution-adjusted): -29753649.635036495
Buyback yield (%): 0
Retained earnings: 218415693.4306569
Inventory turnover: 1.1147407885745098
Receivables turnover: 2.424322652617162
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8571257910179164
FCF margin (%): -1.8571384964023565
Revenue growth (%): 10.765726859669456
Rule of 40 score: 8.9085883632671
Financial ratios for GMAT3.SA — quarterly report dated 2025-09-30
Total revenue: 2023221428.5714285
Gross profit: 430972556.39097744
Operating income: 126138157.89473684
Net income: 159877067.6691729
Capital expenditures: 131653947.36842105
Operating cash flow: 47456203.0075188
Depreciation & amortization: 30482330.827067666
Net tangible assets: 1778916541.3533833
Owner earnings: 58705451.12781954
Return on net tangible assets (%): 3.3000677526533635
Capex to operating income (%): 104.372815939081
Buffett classification: The Gruesome
Stock price: 1.2932330827067668
P/E ratio: 10.966896977155791
Shares outstanding: 2302987204
Book value: 2114924436.0902257
P/B ratio: 1.4082296229784066
Market cap (USD): 2978299241.263158
Debt to equity: 0.5834584288992354
Current ratio: 1.9309293132491225
Quick ratio: 1.0456260666405113
Effective tax rate (%): -87.08464822721368
Interest coverage ratio: 3.8473512211902308
COGS to revenue (%): 78.69869554044404
SG&A to revenue (%): 5.328025041580195
Free cash flow (dilution-adjusted): 153931578.9473684
Buyback yield (%): 0.10733026745820316
Retained earnings: 223657142.85714284
Inventory turnover: 1.4913999584488022
Receivables turnover: 2.7152689730121358
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.883306426328025
FCF margin (%): 7.608241825318032
Revenue growth (%): 26.283748307690995
Rule of 40 score: 33.89199013300903
Financial ratios for GMAT3.SA — quarterly report dated 2025-12-31
Total revenue: 1925168613.138686
Gross profit: 433340510.94890505
Operating income: 82747810.21897809
Net income: 62582481.75182481
Capital expenditures: 200756386.86131385
Operating cash flow: 206145437.95620435
Depreciation & amortization: 29022627.737226274
Net tangible assets: 1775954927.0072992
Owner earnings: -109151277.37226276
Return on net tangible assets (%): -6.146061237950221
Capex to operating income (%): 242.61232572807185
Buffett classification: The Gruesome
Stock price: 0.8096947935368042
P/E ratio: 5.580407651195402
Shares outstanding: 2302987204
Book value: 2092667153.2846718
P/B ratio: 0.891071829427725
Market cap (USD): 1864716748.660682
Debt to equity: 0.601613942881539
Current ratio: 1.7477461711701219
Quick ratio: 1.0443921986948856
Effective tax rate (%): -133.78893335060297
COGS to revenue (%): 77.49077623687147
SG&A to revenue (%): 6.365685667498648
Free cash flow (dilution-adjusted): 5389051.094890511
Buyback yield (%): 0
Retained earnings: 232829562.04379562
Inventory turnover: 1.5928425119206713
Receivables turnover: 2.5852017574597697
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6588173376341167
FCF margin (%): 0.2799261871459927
Revenue growth (%): -4.846370943291979
Rule of 40 score: -4.566444756145986
Financial ratios for GMAT3.SA — annual report dated 2025-12-31
Total revenue: 7011752372.2627735
Gross profit: 1570657116.788321
Operating income: 412589233.5766423
Net income: 338922080.2919708
Capital expenditures: 181333394.1605839
Operating cash flow: 357597262.7737226
Depreciation & amortization: 98466423.35766423
Net tangible assets: 1775954927.0072992
Owner earnings: 256055109.4890511
Return on net tangible assets (%): 14.417883336742968
Capex to operating income (%): 43.950103251276325
Buffett classification: The Good
Stock price: 0.8096947935368042
P/E ratio: 5.50190399827089
Shares outstanding: 2302987204
Book value: 2092667153.2846718
P/B ratio: 0.891071829427725
Market cap (USD): 1864716748.660682
Debt to equity: 0.601613942881539
Current ratio: 1.7477461711701219
Quick ratio: 1.0443921986948856
Effective tax rate (%): -38.050824717977
Interest coverage ratio: 5.748837386694466
COGS to revenue (%): 77.59964936865772
SG&A to revenue (%): 5.686779310533464
Free cash flow (dilution-adjusted): 148630656.93430656
Buyback yield (%): 0.3249940765778445
Retained earnings: 232829562.04379562
Inventory turnover: 5.809521768364594
Receivables turnover: 9.41569192014487
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.257141242187862
FCF margin (%): 2.1197362519854894
Revenue growth (%): 35.05392435651454
Rule of 40 score: 37.17366060850003
Financial ratios for GNC.AX — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.4028776978417272
Shares outstanding: 222323646
Market cap (USD): 756540176.6762592
Buyback yield (%): 0.23773504785705285
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GNC.AX — annual report dated 2022-09-30
Total revenue: 5100000000
Gross profit: 1088311688.3116882
Operating income: 639285714.2857143
Net income: 247012987.01298702
Capital expenditures: 50974025.97402597
Depreciation & amortization: 76168831.16883117
Net tangible assets: 879025974.025974
Owner earnings: 272207792.2077922
Return on net tangible assets (%): 30.966979389820494
Capex to operating income (%): 7.973590655154901
Buffett classification: The Great
Stock price: 3.935064935064935
P/E ratio: 3.5417489347003155
Shares outstanding: 222323646
Book value: 943311688.3116882
P/B ratio: 0.9274325702209679
Market cap (USD): 874857983.6103896
Debt to equity: 0.7598265299098232
Current ratio: 1.4894652620349378
Quick ratio: 0.9177223629817308
Effective tax rate (%): 30.848936556989635
Interest coverage ratio: 26.253333333333334
COGS to revenue (%): 78.66055513114335
SG&A to revenue (%): 5.045836516424751
Free cash flow (dilution-adjusted): 235649350.64935064
Buyback yield (%): 4.082295227723585
Retained earnings: 594220779.2207792
Inventory turnover: 7.204664723032071
Receivables turnover: 12.731398930134544
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 53.3546499024496
FCF margin (%): 4.620575502928443
Rule of 40 score: 4.620575502928443
Financial ratios for GNC.AX — annual report dated 2023-09-30
Total revenue: 5265448717.948718
Gross profit: 843974358.9743589
Operating income: 358461538.46153843
Net income: 160064102.56410256
Capital expenditures: 41666666.666666664
Depreciation & amortization: 74935897.43589744
Net tangible assets: 957051282.051282
Owner earnings: 193333333.33333334
Return on net tangible assets (%): 20.200937709310114
Capex to operating income (%): 11.623748211731044
Buffett classification: The Great
Stock price: 3.7628205128205128
P/E ratio: 5.226430925190228
Shares outstanding: 222323646
Book value: 1020384615.3846157
P/B ratio: 0.8198516157934411
Market cap (USD): 836563975.6538461
Debt to equity: 0.7580098002261588
Current ratio: 1.6541816671282192
Quick ratio: 1.081002492384381
Effective tax rate (%): 32.640949554896146
Interest coverage ratio: 7.608163265306122
COGS to revenue (%): 83.97146370265762
SG&A to revenue (%): 5.24464031360709
Free cash flow (dilution-adjusted): 326282051.28205127
Buyback yield (%): 0
Retained earnings: 669358974.3589743
Inventory turnover: 8.331320207754558
Receivables turnover: 13.765879001173118
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 28.322528363046995
FCF margin (%): 6.1966618375719795
Revenue growth (%): 3.2440925087983934
Rule of 40 score: 9.440754346370372
Financial ratios for GNC.AX — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 958344827.5862069
Buffett classification: The Gruesome
Stock price: 5.63448275862069
Shares outstanding: 222323646
Book value: 1036344827.5862069
P/B ratio: 1.208747047195049
Market cap (USD): 1252678750.2206898
Debt to equity: 0.6255406934185134
Current ratio: 1.8012379642365888
Quick ratio: 1.2753979170760463
Buyback yield (%): 0
Retained earnings: 679517241.3793104
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GNC.AX — annual report dated 2024-09-30
Total revenue: 4476206896.551724
Gross profit: 469241379.3103448
Operating income: 14344827.586206896
Net income: 42620689.655172415
Capital expenditures: 36827586.20689655
Depreciation & amortization: 67724137.93103449
Net tangible assets: 958344827.5862069
Owner earnings: 73517241.37931037
Return on net tangible assets (%): 7.67127230857801
Capex to operating income (%): 256.7307692307692
Buffett classification: The Gruesome
Stock price: 5.63448275862069
P/E ratio: 29.3913299
Shares outstanding: 222323646
Book value: 1036344827.5862069
P/B ratio: 1.208747047195049
Market cap (USD): 1252678750.2206898
Debt to equity: 0.6255406934185134
Current ratio: 1.8012379642365888
Quick ratio: 1.2753979170760463
Effective tax rate (%): 24.90886998784933
Interest coverage ratio: 0.2905027932960894
COGS to revenue (%): 89.51698636468684
SG&A to revenue (%): 6.047299899853632
Free cash flow (dilution-adjusted): 52413793.10344828
Buyback yield (%): 1.4809642244400407
Retained earnings: 679517241.3793104
Inventory turnover: 10.855941704035873
Receivables turnover: 11.017654048548634
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.102220338084892
FCF margin (%): 1.1709421462136969
Revenue growth (%): -14.989070517516346
Rule of 40 score: -13.818128371302649
Financial ratios for GU81.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.034090909090909
Shares outstanding: 2991046666
Market cap (USD): 15057200829.977272
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GU81.DE — annual report dated 2022-12-31
Total revenue: -23539759036.14458
Net income: -1240963855.421687
Capital expenditures: 22891566.265060242
Operating cash flow: 19136144578.313255
Depreciation & amortization: 321686746.9879518
Net tangible assets: 8267469879.518073
Owner earnings: -942168674.6987953
Return on net tangible assets (%): -11.39609443310988
Buffett classification: The Gruesome
Stock price: 5.074468085106383
Shares outstanding: 2991046666
Book value: 12306024096.385498
P/B ratio: 1.2333773060089241
Market cap (USD): 15177970847.680851
Debt to equity: 0.7900920305463118
Free cash flow (dilution-adjusted): 18946987951.80723
Buyback yield (%): 33.02979734484207
Retained earnings: -2804819277.1084337
Receivables turnover: -5.614367816091955
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GU81.DE — annual report dated 2023-12-31
Total revenue: 51210126582.27848
Net income: 1400000000
Capital expenditures: 188607594.93670884
Operating cash flow: -3458227848.1012654
Depreciation & amortization: 308860759.4936709
Net tangible assets: 7865822784.810126
Owner earnings: 1520253164.556962
Return on net tangible assets (%): 19.327325394271003
Buffett classification: The Gruesome
Stock price: 5.3
P/E ratio: 11.323248092714286
Shares outstanding: 2991046666
Book value: 12151898734.177246
P/B ratio: 1.304532540681455
Market cap (USD): 15852547329.8
Debt to equity: 0.7673958333333313
Effective tax rate (%): 23.247744621790424
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -3978481012.658228
Buyback yield (%): 3.0023526010479493
Retained earnings: 2820253164.556962
Receivables turnover: 10.87234614350981
Capitalized R&D asset: 0
FCF margin (%): -7.768934150682223
Rule of 40 score: -7.768934150682223
Financial ratios for GU81.DE — annual report dated 2024-12-31
Total revenue: 49880000000
Net income: 881250000
Capital expenditures: 62500000
Operating cash flow: 10556250000
Depreciation & amortization: 305000000
Net tangible assets: 5737500000
Owner earnings: 1123750000
Return on net tangible assets (%): 19.586056644880173
Buffett classification: The Gruesome
Stock price: 4.96875
P/E ratio: 16.86441205297872
Shares outstanding: 2991046666
Book value: 10776250000
P/B ratio: 1.3791219693017052
Market cap (USD): 14861763121.6875
Debt to equity: 0.7987472450991764
Effective tax rate (%): 29.287863590772318
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 10263750000
Buyback yield (%): 2.9690286165044033
Retained earnings: 1735000000
Receivables turnover: 10.465250458956202
Capitalized R&D asset: 0
FCF margin (%): 20.57688452285485
Revenue growth (%): -2.597389756772789
Rule of 40 score: 17.979494766082063
Financial ratios for GU81.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 5737500000
Buffett classification: The Gruesome
Stock price: 4.96875
Shares outstanding: 2991046666
Book value: 10776250000
P/B ratio: 1.3791219693017052
Market cap (USD): 14861763121.6875
Debt to equity: 0.7987472450991764
Buyback yield (%): 0
Retained earnings: 1735000000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GU81.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 6467123287.671233
Buffett classification: The Gruesome
Stock price: 5.6117647058823525
Shares outstanding: 2991046666
Book value: 11610958904.109558
P/B ratio: 1.445621352424649
Market cap (USD): 16785050113.905882
Debt to equity: 0.7214487966021728
Buyback yield (%): 0
Retained earnings: 1836986301.369863
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HCWC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.49
Shares outstanding: 26590544
Market cap (USD): 66210454.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HCWC — annual report dated 2024-12-31
Total revenue: 69370803
Gross profit: 27065309
Operating income: -1982624
Net income: -4506466
Capital expenditures: 497207
Operating cash flow: -3064842
Depreciation & amortization: 4850054
Net tangible assets: -5273477
Owner earnings: -153619
Buffett classification: The Gruesome
Stock price: 1.18
Shares outstanding: 26590544
Book value: 2380001
P/B ratio: 13.18354148590694
Market cap (USD): 31376841.919999998
Debt to equity: 10.722905578611101
Current ratio: 0.8129566620238514
Quick ratio: 0.2731416672243014
Interest coverage ratio: -2.3362065207016784
COGS to revenue (%): 60.98458165461916
SG&A to revenue (%): 41.87342764361543
Free cash flow (dilution-adjusted): -3316635
Buyback yield (%): 0
Retained earnings: -730907
Inventory turnover: 6.563509454570278
Receivables turnover: 99.09675857212038
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.941934685428658
FCF margin (%): -4.781024374188085
Revenue growth (%): 24.566458704560098
Rule of 40 score: 19.785434330372013
Financial ratios for HCWC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.18
Shares outstanding: 26590544
Market cap (USD): 31376841.919999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HCWC — quarterly report dated 2025-03-31
Total revenue: 20259606
Gross profit: 7851910
Operating income: -409675
Net income: -712410
Capital expenditures: 127419
Operating cash flow: 1092748
Depreciation & amortization: 1347604
Net tangible assets: -5231859
Owner earnings: 507775
Buffett classification: The Gruesome
Stock price: 0.5
Shares outstanding: 26590544
Book value: 2125091
P/B ratio: 6.256330670074835
Market cap (USD): 13295272
Debt to equity: 11.268653907056216
Current ratio: 0.8175906916405211
Quick ratio: 0.29017497959740934
Interest coverage ratio: -1.3759904074483342
COGS to revenue (%): 61.24352072789569
SG&A to revenue (%): 40.77860645463688
Free cash flow (dilution-adjusted): 965329
Buyback yield (%): 0
Retained earnings: -1443317
Inventory turnover: 1.761880453027937
Receivables turnover: 12.426324447459423
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9759811752794059
FCF margin (%): 4.764796511837397
Rule of 40 score: 4.764796511837397
Financial ratios for HCWC — quarterly report dated 2025-06-30
Total revenue: 20199979
Gross profit: 8093376
Operating income: 323047
Net income: -339359
Capital expenditures: 78467
Operating cash flow: 1067037
Depreciation & amortization: 1363117
Net tangible assets: -1298036
Owner earnings: 945291
Capex to operating income (%): 24.2896544465666
Buffett classification: The Great
Stock price: 0.4
Shares outstanding: 26590544
Book value: 5762386
P/B ratio: 1.8458009581447685
Market cap (USD): 10636217.600000001
Debt to equity: 3.8410144686593366
Current ratio: 1.0959295794073802
Quick ratio: 0.5786198909077855
Interest coverage ratio: 1.2011191463255935
COGS to revenue (%): 59.93374052517579
SG&A to revenue (%): 31.42302771700901
Free cash flow (dilution-adjusted): 988570
Buyback yield (%): 0
Retained earnings: -1782676
Inventory turnover: 1.7686775301632447
Receivables turnover: 7.878104151765204
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3942592670439797
FCF margin (%): 4.893915978823542
Revenue growth (%): -0.29431470681117883
Rule of 40 score: 4.599601272012364
Financial ratios for HCWC — quarterly report dated 2025-09-30
Total revenue: 19039927
Gross profit: 7391629
Operating income: -609422
Net income: -1224139
Capital expenditures: 42681
Operating cash flow: -308651
Depreciation & amortization: 1371247
Net tangible assets: -850146
Owner earnings: 104427
Buffett classification: The Gruesome
Stock price: 0.76
Shares outstanding: 26590544
Book value: 5913747
P/B ratio: 3.417260400216648
Market cap (USD): 20208813.44
Debt to equity: 3.3767917362714366
Current ratio: 0.9783452126454973
Quick ratio: 0.53092056165379
Interest coverage ratio: -2.5254420607261108
COGS to revenue (%): 61.17827027383036
SG&A to revenue (%): 42.022487796303
Free cash flow (dilution-adjusted): -351332
Buyback yield (%): 0
Retained earnings: -3006815
Inventory turnover: 1.9349557220765026
Receivables turnover: 5.228973623242218
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.005525252059973
FCF margin (%): -1.8452381671421325
Revenue growth (%): -5.742837653445085
Rule of 40 score: -7.588075820587218
Financial ratios for HCWC — annual report dated 2025-12-31
Total revenue: 78205678
Gross profit: 30657164
Operating income: -2484116
Net income: -3935802
Capital expenditures: 308918
Operating cash flow: 996054
Depreciation & amortization: 5446260
Net tangible assets: 795421
Owner earnings: 1201540
Buffett classification: The Gruesome
Stock price: 0.25
Shares outstanding: 26590544
Book value: 7305036
P/B ratio: 0.9100072881228785
Market cap (USD): 6647636
Debt to equity: 2.4685375951603796
Current ratio: 0.7852882197155838
Quick ratio: 0.3143815386861185
Interest coverage ratio: -2.4525492387480736
COGS to revenue (%): 60.79931178398581
SG&A to revenue (%): 42.37707650843459
Free cash flow (dilution-adjusted): 577920
Buyback yield (%): 0
Retained earnings: -4666709
Inventory turnover: 7.9416123764084485
Receivables turnover: 214.88913679640595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.952409498526972
FCF margin (%): 0.7389744770194306
Revenue growth (%): 12.735725431922706
Rule of 40 score: 13.474699908942137
Financial ratios for HCWC — quarterly report dated 2025-12-31
Total revenue: 18706166
Gross profit: 7320250
Operating income: -1425985
Net income: -1659894
Capital expenditures: 60351
Operating cash flow: -855080
Depreciation & amortization: 1364292
Net tangible assets: 795421
Owner earnings: -355953
Return on net tangible assets (%): -44.750264325432696
Buffett classification: The Gruesome
Stock price: 0.25
Shares outstanding: 26590544
Book value: 7305036
P/B ratio: 0.9100072881228785
Market cap (USD): 6647636
Debt to equity: 2.4685375951603796
Current ratio: 0.7852882197155838
Quick ratio: 0.3143815386861185
Interest coverage ratio: -6.960336403528039
COGS to revenue (%): 60.86718144167009
SG&A to revenue (%): 46.75589321724185
Free cash flow (dilution-adjusted): -927147
Buyback yield (%): 0
Retained earnings: -4666709
Inventory turnover: 1.9016899544399426
Receivables turnover: 51.39974445986234
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.86117583025792
FCF margin (%): -4.956371070373266
Revenue growth (%): -1.7529531494527264
Rule of 40 score: -6.709324219825993
Financial ratios for INKT — annual report dated 2021-12-31
Capital expenditures: 248983
Buffett classification: The Gruesome
Stock price: 44.6
Shares outstanding: 4981899
Market cap (USD): 222192695.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INKT — annual report dated 2022-12-31
Total revenue: 0
Operating income: -30949278
Net income: -27991212
Capital expenditures: 250046
Operating cash flow: -18866843
Depreciation & amortization: 121749
Net tangible assets: -401303
Owner earnings: -28119509
Buffett classification: The Gruesome
Stock price: 26.1
Shares outstanding: 4981899
Book value: -401303
Market cap (USD): 130027563.9
Debt to equity: 0
Current ratio: 1.6088011463383827
Quick ratio: 1.6088011463383827
Free cash flow (dilution-adjusted): -22143735
Buyback yield (%): 0.12089282863200668
Retained earnings: -110939074
Capitalized R&D asset: 23115123
ROCI (R&D-adjusted, %): -48.706779077531756
Rule of 40 score: 0
Financial ratios for INKT — annual report dated 2023-12-31
Total revenue: 0
Operating income: -22921105
Net income: -22457859
Capital expenditures: 73561
Operating cash flow: -15762512
Depreciation & amortization: 204617
Net tangible assets: -18055449
Owner earnings: -22326803
Buffett classification: The Gruesome
Stock price: 10.7
Shares outstanding: 4981899
Book value: -18055449
Market cap (USD): 53306319.3
Debt to equity: 0
Current ratio: 0.3155691450666669
Quick ratio: 0.3155691450666669
Free cash flow (dilution-adjusted): -19696439
Buyback yield (%): 0.8960269744228992
Retained earnings: -133396933
Capitalized R&D asset: 30977129.41
ROCI (R&D-adjusted, %): -84.13656164196256
Rule of 40 score: 0
Financial ratios for INKT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.5
Shares outstanding: 4981899
Market cap (USD): 37364242.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INKT — annual report dated 2024-12-31
Total revenue: 0
Operating income: -10650239
Net income: -10784802
Capital expenditures: 0
Operating cash flow: -9555476
Depreciation & amortization: 215437
Net tangible assets: -19585882
Owner earnings: -10569365
Buffett classification: The Gruesome
Stock price: 6.97
Shares outstanding: 4981899
Book value: -19585882
Market cap (USD): 34723836.03
Debt to equity: -0.25143682577072607
Current ratio: 0.7166833628462015
Quick ratio: 0.7166833628462015
Free cash flow (dilution-adjusted): -11365702
Buyback yield (%): 0
Retained earnings: -144181735
Capitalized R&D asset: 24342363.580000002
ROCI (R&D-adjusted, %): -83.51358819639675
Rule of 40 score: 0
Financial ratios for INKT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.97
Shares outstanding: 4981899
Market cap (USD): 34723836.03
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INKT — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -2532765
Net income: -2766697
Capital expenditures: 0
Operating cash flow: -1340876
Depreciation & amortization: 50765
Net tangible assets: -21791779
Owner earnings: -2715932
Buffett classification: The Gruesome
Stock price: 8.64
Shares outstanding: 4981899
Book value: -21791779
Market cap (USD): 43043607.36
Debt to equity: -0.2348378257690664
Current ratio: 0.29536247613152633
Quick ratio: 0.29536247613152633
Free cash flow (dilution-adjusted): -1931965
Buyback yield (%): 0
Retained earnings: -146948432
Capitalized R&D asset: 1261902
Rule of 40 score: 0
Financial ratios for INKT — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -3688306
Net income: -4237751
Capital expenditures: 0
Operating cash flow: -1569218
Depreciation & amortization: 48763
Net tangible assets: -25189315
Owner earnings: -4188988
Buffett classification: The Gruesome
Stock price: 7.39
Shares outstanding: 4981899
Book value: -25189315
Market cap (USD): 36816233.61
Debt to equity: -0.21859848114170632
Current ratio: 0.15278551061205684
Quick ratio: 0.15278551061205684
Free cash flow (dilution-adjusted): -2465770
Buyback yield (%): 0
Retained earnings: -151186183
Capitalized R&D asset: 2684650.34
Rule of 40 score: 0
Financial ratios for INKT — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -2989673
Net income: -2887709
Capital expenditures: 0
Operating cash flow: -941348
Depreciation & amortization: 43654
Net tangible assets: -13512982
Owner earnings: -2844055
Buffett classification: The Gruesome
Stock price: 14
Shares outstanding: 4981899
Book value: -13512982
Market cap (USD): 69746586
Debt to equity: -0.4236864224343672
Current ratio: 1.0819416068152925
Quick ratio: 1.0819416068152925
Free cash flow (dilution-adjusted): -1561933
Buyback yield (%): 0
Retained earnings: -154073892
Capitalized R&D asset: 2791853.58
ROCI (R&D-adjusted, %): -75.4575133514861
Rule of 40 score: 0
Financial ratios for INKT — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -3276559
Net income: -2602103
Capital expenditures: 0
Operating cash flow: -2073726
Depreciation & amortization: 38563
Net tangible assets: -14227659
Owner earnings: -2563540
Buffett classification: The Gruesome
Stock price: 11.15
Shares outstanding: 4981899
Book value: -14227659
Market cap (USD): 55548173.85
Debt to equity: -0.36404049323926024
Current ratio: 1.0626580407641577
Quick ratio: 1.0626580407641577
Free cash flow (dilution-adjusted): -2639497
Buyback yield (%): 0
Retained earnings: -156675995
Capitalized R&D asset: 2886089.34
ROCI (R&D-adjusted, %): -79.6841075372904
Rule of 40 score: 0
Financial ratios for INKT — annual report dated 2025-12-31
Total revenue: 0
Operating income: -12487304
Net income: -12494260
Capital expenditures: 0
Operating cash flow: -5925168
Depreciation & amortization: 181745
Net tangible assets: -14227659
Owner earnings: -12312515
Buffett classification: The Gruesome
Stock price: 11.15
Shares outstanding: 4981899
Book value: -14227659
Market cap (USD): 55548173.85
Debt to equity: -0.36404049323926024
Current ratio: 1.0626580407641577
Quick ratio: 1.0626580407641577
Free cash flow (dilution-adjusted): -8599165
Buyback yield (%): 0
Retained earnings: -156675995
Capitalized R&D asset: 15114356.26
ROCI (R&D-adjusted, %): -97.56512881889094
Rule of 40 score: 0
Financial ratios for IQV — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 282.14
Shares outstanding: 166900000
Market cap (USD): 47089166000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IQV — annual report dated 2022-12-31
Total revenue: 14410000000
Gross profit: 5028000000
Operating income: 1827000000
Net income: 1091000000
Capital expenditures: 674000000
Operating cash flow: 2260000000
Depreciation & amortization: 1130000000
Net tangible assets: -12976000000
Owner earnings: 1547000000
Return on net tangible assets (%): -11.92200986436498
Capex to operating income (%): 36.89107827038862
Buffett classification: The Good
Stock price: 204.89
P/E ratio: 31.34385059578368
Shares outstanding: 166900000
Book value: 5765000000
P/B ratio: 5.931681006071119
Market cap (USD): 34196140999.999996
Debt to equity: 2.256895056374675
Current ratio: 0.8929723915381858
Quick ratio: 0.8929723915381858
Effective tax rate (%): 19.075568598679386
Interest coverage ratio: 4.391826923076923
COGS to revenue (%): 65.10756419153367
SG&A to revenue (%): 14.371963913948646
Free cash flow (dilution-adjusted): 1392000000
Buyback yield (%): 3.415590080763792
Retained earnings: 3334000000
Receivables turnover: 4.868243243243243
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.246419353206134
FCF margin (%): 9.659958362248439
Rule of 40 score: 9.659958362248439
Financial ratios for IQV — annual report dated 2023-12-31
Total revenue: 14984000000
Gross profit: 5239000000
Operating income: 2061000000
Net income: 1358000000
Capital expenditures: 649000000
Operating cash flow: 2149000000
Depreciation & amortization: 1125000000
Net tangible assets: -13294000000
Owner earnings: 1834000000
Return on net tangible assets (%): -13.795697307055816
Capex to operating income (%): 31.48956817079088
Buffett classification: The Good
Stock price: 231.38
P/E ratio: 28.436908689248895
Shares outstanding: 166900000
Book value: 6112000000
P/B ratio: 6.318279123036649
Market cap (USD): 38617322000
Debt to equity: 2.2735602094240837
Current ratio: 0.8621167770759514
Quick ratio: 0.8621167770759514
Effective tax rate (%): 6.922549691569568
Interest coverage ratio: 3.0669642857142856
COGS to revenue (%): 65.03603844100374
SG&A to revenue (%): 13.701281366791243
Free cash flow (dilution-adjusted): 1283000000
Buyback yield (%): 2.5687954229451746
Retained earnings: 4692000000
Receivables turnover: 4.3902724875476125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.208023774145616
FCF margin (%): 8.562466631073145
Revenue growth (%): 3.9833448993754335
Rule of 40 score: 12.545811530448578
Financial ratios for IQV — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 236.97
Shares outstanding: 166900000
Market cap (USD): 39550293000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IQV — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 196.51
Shares outstanding: 166900000
Market cap (USD): 32797519000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IQV — annual report dated 2024-12-31
Total revenue: 15405000000
Gross profit: 5375000000
Operating income: 2269000000
Net income: 1373000000
Capital expenditures: 577000000
Operating cash flow: 2716000000
Depreciation & amortization: 1114000000
Net tangible assets: -13142000000
Owner earnings: 1910000000
Return on net tangible assets (%): -14.533556536295844
Capex to operating income (%): 25.429704715733802
Buffett classification: The Good
Stock price: 196.51
P/E ratio: 23.88748652585579
Shares outstanding: 166900000
Book value: 6067000000
P/B ratio: 5.405887423767925
Market cap (USD): 32797519000
Debt to equity: 2.3332783912971813
Current ratio: 0.8378611470461406
Quick ratio: 0.8378611470461406
Effective tax rate (%): 18.034751348112643
Interest coverage ratio: 3.3865671641791044
COGS to revenue (%): 65.10873093151575
SG&A to revenue (%): 12.930866601752678
Free cash flow (dilution-adjusted): 1908000000
Buyback yield (%): 4.1161650062616015
Retained earnings: 6065000000
Receivables turnover: 4.75462962962963
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.377996188947948
FCF margin (%): 12.385589094449854
Revenue growth (%): 2.8096636412172984
Rule of 40 score: 15.195252735667152
Financial ratios for IQV — quarterly report dated 2025-03-31
Total revenue: 3829000000
Gross profit: 1298000000
Operating income: 525000000
Net income: 249000000
Capital expenditures: 142000000
Operating cash flow: 568000000
Depreciation & amortization: 265000000
Net tangible assets: -13553000000
Owner earnings: 372000000
Return on net tangible assets (%): -2.7447797535600973
Capex to operating income (%): 27.047619047619047
Buffett classification: The Good
Stock price: 176.3
P/E ratio: 29.542640562248994
Shares outstanding: 166900000
Book value: 5985000000
P/B ratio: 4.91636925647452
Market cap (USD): 29424470000
Debt to equity: 2.423893065998329
Current ratio: 0.8233737289316061
Quick ratio: 0.8233737289316061
Effective tax rate (%): 18.885448916408667
Interest coverage ratio: 3.1818181818181817
COGS to revenue (%): 66.10080961086446
SG&A to revenue (%): 13.267171585270304
Free cash flow (dilution-adjusted): 354000000
Buyback yield (%): 1.2744494633208348
Retained earnings: 6314000000
Receivables turnover: 1.1564482029598309
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.606364493868838
FCF margin (%): 9.245233742491513
Rule of 40 score: 9.245233742491513
Financial ratios for IQV — quarterly report dated 2025-06-30
Total revenue: 4017000000
Gross profit: 1323000000
Operating income: 538000000
Net income: 266000000
Capital expenditures: 151000000
Operating cash flow: 443000000
Depreciation & amortization: 276000000
Net tangible assets: -14429000000
Owner earnings: 391000000
Return on net tangible assets (%): -2.7098205003811766
Capex to operating income (%): 28.066914498141266
Buffett classification: The Good
Stock price: 157.59
P/E ratio: 51.0714
Shares outstanding: 166900000
Book value: 5786000000
P/B ratio: 4.545760629104735
Market cap (USD): 26301771000
Debt to equity: 2.7134462495679226
Current ratio: 0.8379556259904913
Quick ratio: 0.8379556259904913
Effective tax rate (%): 17.3374613003096
Interest coverage ratio: 2.956043956043956
COGS to revenue (%): 67.06497386109037
SG&A to revenue (%): 12.671147622603934
Free cash flow (dilution-adjusted): 232000000
Buyback yield (%): 2.49793065265453
Retained earnings: 6580000000
Receivables turnover: 1.1793893129770991
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5546058879392213
FCF margin (%): 5.775454319143639
Revenue growth (%): 4.909898145729956
Rule of 40 score: 10.685352464873596
Financial ratios for IQV — quarterly report dated 2025-09-30
Total revenue: 4100000000
Gross profit: 1373000000
Operating income: 573000000
Net income: 332000000
Capital expenditures: 61000000
Operating cash flow: 908000000
Depreciation & amortization: 286000000
Net tangible assets: -14495000000
Owner earnings: 557000000
Return on net tangible assets (%): -3.842704380820973
Capex to operating income (%): 10.645724258289704
Buffett classification: The Great
Stock price: 189.94
P/E ratio: 37.42737426210154
Shares outstanding: 166900000
Book value: 6288000000
P/B ratio: 5.041505407124681
Market cap (USD): 31700986000
Debt to equity: 2.415712468193384
Current ratio: 0.7027503526093088
Quick ratio: 0.7027503526093088
Effective tax rate (%): 18.627450980392158
Interest coverage ratio: 3.0317460317460316
COGS to revenue (%): 66.51219512195122
SG&A to revenue (%): 12.536585365853659
Free cash flow (dilution-adjusted): 717000000
Buyback yield (%): 0
Retained earnings: 6911000000
Receivables turnover: 1.2371756185878093
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8339680498540973
FCF margin (%): 17.48780487804878
Revenue growth (%): 2.0662185710729397
Rule of 40 score: 19.554023449121722
Financial ratios for IQV — annual report dated 2025-12-31
Total revenue: 16310000000
Gross profit: 5430000000
Operating income: 2287000000
Net income: 1361000000
Capital expenditures: 528000000
Operating cash flow: 2654000000
Depreciation & amortization: 1144000000
Net tangible assets: -15075000000
Owner earnings: 1977000000
Return on net tangible assets (%): -13.114427860696518
Capex to operating income (%): 23.087013554875384
Buffett classification: The Great
Stock price: 225.41
P/E ratio: 27.6421227038942
Shares outstanding: 166900000
Book value: 6630000000
P/B ratio: 5.67434826546003
Market cap (USD): 37620929000
Debt to equity: 2.405580693815988
Current ratio: 0.7494603022307508
Quick ratio: 0.7494603022307508
Effective tax rate (%): 15.83909490886235
Interest coverage ratio: 3.1371742112482854
COGS to revenue (%): 66.70754138565297
SG&A to revenue (%): 12.256284488044145
Free cash flow (dilution-adjusted): 1804000000
Buyback yield (%): 3.3066700718634565
Retained earnings: 7425000000
Receivables turnover: 4.759264662970528
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.585022678885494
FCF margin (%): 11.060698957694665
Revenue growth (%): 5.874716001298279
Rule of 40 score: 16.935414958992943
Financial ratios for IQV — quarterly report dated 2025-12-31
Total revenue: 4364000000
Gross profit: 1436000000
Operating income: 651000000
Net income: 514000000
Capital expenditures: 174000000
Operating cash flow: 735000000
Depreciation & amortization: 317000000
Net tangible assets: -15075000000
Owner earnings: 657000000
Return on net tangible assets (%): -4.358208955223881
Capex to operating income (%): 26.72811059907834
Buffett classification: The Good
Stock price: 225.41
P/E ratio: 27.6421227038942
Shares outstanding: 166900000
Book value: 6630000000
P/B ratio: 5.67434826546003
Market cap (USD): 37620929000
Debt to equity: 2.405580693815988
Current ratio: 0.7494603022307508
Quick ratio: 0.7494603022307508
Effective tax rate (%): 10.986964618249534
Interest coverage ratio: 3.373056994818653
COGS to revenue (%): 67.09440879926673
SG&A to revenue (%): 10.724106324472961
Free cash flow (dilution-adjusted): 501000000
Buyback yield (%): 0.5635161215715859
Retained earnings: 7425000000
Receivables turnover: 1.2734169827837758
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.013051930019439
FCF margin (%): 11.480293308890925
Revenue growth (%): 6.439024390243903
Rule of 40 score: 17.91931769913483
Financial ratios for ITX.MC — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.22222222222222
Shares outstanding: 3113366768
Market cap (USD): 78526028481.77777
Buyback yield (%): 0.10046208934047303
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITX.MC — annual report dated 2023-01-31
Total revenue: 35401086956.521736
Gross profit: 20172826086.95652
Operating income: 6407608695.652174
Net income: 4507608695.652174
Capital expenditures: 1116304347.826087
Operating cash flow: 7254347826.086956
Depreciation & amortization: 3017391304.347826
Net tangible assets: 17396739130.43478
Owner earnings: 6408695652.173913
Return on net tangible assets (%): 36.838487972508595
Capex to operating income (%): 17.421543681085666
Buffett classification: The Great
Stock price: 27.565217391304348
P/E ratio: 19.03905985929105
Shares outstanding: 3113366768
Book value: 18514130434.782608
P/B ratio: 4.6354125072788115
Market cap (USD): 85820631778.78261
Debt to equity: 0.3285387189573182
Current ratio: 1.7990659948383925
Quick ratio: 1.406906722379255
Effective tax rate (%): 22.601717058603956
Interest coverage ratio: 40.9375
COGS to revenue (%): 43.01943565967638
SG&A to revenue (%): 9.533605575854342
Free cash flow (dilution-adjusted): 5716304347.826087
Buyback yield (%): 0.07725921663801984
Retained earnings: 17891304347.826088
Inventory turnover: 4.390786587276716
Receivables turnover: 55.20169491525424
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.984344960175775
FCF margin (%): 16.147256593693392
Rule of 40 score: 16.147256593693392
Financial ratios for ITX.MC — annual report dated 2024-01-31
Total revenue: 39072826086.95652
Gross profit: 22567391304.347824
Operating income: 7515217391.304347
Net income: 5864130434.782608
Capital expenditures: 1520652173.9130435
Operating cash flow: 9420652173.913044
Depreciation & amortization: 3148913043.4782605
Net tangible assets: 18719565217.391304
Owner earnings: 7492391304.347824
Return on net tangible assets (%): 40.02438741145046
Capex to operating income (%): 20.23430720277698
Buffett classification: The Great
Stock price: 39.71739130434782
P/E ratio: 21.086639796611678
Shares outstanding: 3113366768
Book value: 20295652173.91304
P/B ratio: 6.092674684164525
Market cap (USD): 123654806198.60867
Debt to equity: 0.3073586118251928
Current ratio: 1.792100257357055
Quick ratio: 1.460221550855992
Effective tax rate (%): 21.470160116448326
Interest coverage ratio: 25.512915129151292
COGS to revenue (%): 42.24552813864857
SG&A to revenue (%): 9.369349319831974
Free cash flow (dilution-adjusted): 7385869565.217391
Buyback yield (%): 0
Retained earnings: 19555434782.608696
Inventory turnover: 5.1200269723533385
Receivables turnover: 57.79260450160771
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.052861585007143
FCF margin (%): 18.90282916515982
Revenue growth (%): 10.371825969480184
Rule of 40 score: 29.274655134640003